Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma

PURPOSE: To develop a nomogram that estimates 1-year recurrence-free survival (RFS) after trimodality therapy for esophageal adenocarcinoma and to assess the overall survival (OS) benefit of esophagectomy after chemoradiotherapy (CRT) on the basis of 1-year recurrence risk. METHODS: In total, 568 co...

Descripción completa

Detalles Bibliográficos
Autores principales: Goense, Lucas, van Rossum, Peter S. N., Xi, Mian, Maru, Dipen M., Carter, Brett W., Meijer, Gert J., Ho, Linus, van Hillegersberg, Richard, Hofstetter, Wayne L., Lin, Steven H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928173/
https://www.ncbi.nlm.nih.gov/pubmed/29569125
http://dx.doi.org/10.1245/s10434-018-6435-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928173/
https://www.ncbi.nlm.nih.gov/pubmed/29569125
http://dx.doi.org/10.1245/s10434-018-6435-4

Ejemplares similares